Close Menu

NEW YORK ─ DermTech on Thursday said it has priced an underwritten public offering of 4,237,288 shares of its common stock at $29.50 per share.

The La Jolla, California-based firm expects approximately $125 million in gross proceeds from the offering, before deducting underwriting discounts, commissions, and offering expenses.

In addition, DermTech has granted the underwriters a 30-day option to purchase up to an additional 635,593 shares of common stock at the offering price, less underwriting discounts and commissions.

The offering is expected to close on Jan. 11.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.